DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the AAKAAR MEDICAL TECHNO LTD (AAKAAR) share price today?

AAKAAR MEDICAL TECHNO LTD (AAKAAR) is trading at ₹72 on the NSE, up 1.41% on the day. Source: DocStoX.

What is the PE ratio of AAKAAR MEDICAL TECHNO LTD?

AAKAAR MEDICAL TECHNO LTD has a price-to-earnings (PE) ratio of 12.4 in the Fast Moving Consumer Goods sector.

What is the market capitalisation of AAKAAR MEDICAL TECHNO LTD?

AAKAAR MEDICAL TECHNO LTD has a market capitalisation of approximately ₹0 crore.

AAKAAR MEDICAL TECHNO LTD

AAKAAR·NSE·Fast Moving Consumer Goods

₹72.00▲ +1.00 (+1.41%)

Fast Moving Consumer Goods · Personal Care

A steady, established business

Day₹71.00

₹72.00

52W₹46

₹10544%

Open

₹71.00

High

₹72.00

Low

₹71.00

Prev Close

₹71.00

Volume

4.8K

VWAP

₹71.33

Snapshot

Key fundamentals

Market Cap

₹0 Cr

P/E Ratio

12.44Cheap

P/B Ratio

1.74

EPS

₹5.79

Book Value

₹38.49

ROE

17.10%Strong

ROCE

26.72%Efficient

Dividend Yield

0.00%

Debt / Equity

0.34Moderate

Face Value

₹10.00

52W High

₹105.00

52W Low

₹46.00

Sector

Fast Moving Consumer Goods

Industry

Personal Care

Fairly Valued

Narrow moatMedium uncertainty

Fair value estimate

₹69

▼ 3.6%downside

Trading at ₹72 — 4% above our estimate

BearFair valueBull

₹59₹69₹80

/100

Business quality — Solid

Growth 11Profitability 52Efficiency 47Valuation 88

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 0/9)

Strengths

Low debt relative to equity
Capital is working hard (ROCE 27%)
Reasonably priced at 12× earnings
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 0/9)

How we got there

Fair value methods

Residual income

26% ROE fading to 13% over ~10 yrs, on ₹38 book

₹69

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹71

Analyst target

No analyst coverage

—

Blended fair value₹69

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Capital is working hard (ROCE 27%)
Reasonably priced at 12× earnings
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 0/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

12.4Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

17.1%Strong

Above 15% is considered healthy for Indian equities

ROCE

26.7%Efficient

Above 18% means capital is working hard

Debt/Eq

0.34Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

—

P/B

1.74

EPS

₹5.79

Div Yield

—

What changed

Recent changes

Foreign investors-0.5% stake last quarter
Domestic institutions+0.4% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 12.4×

Growth

Strong

+27% rev CAGR

Profitability

Healthy

17.1% ROE

Financial health

Comfortable

D/E 0.34

Momentum

N/A

No technicals

Today

Trading activity

Delivery %100.0%

Turnover₹3.42L Cr

Trades3

VWAP₹71.33

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+26.9%

+40.0%

10Y

—

Profit

+45.6%

+65.2%

10Y

—

EPS

—

10Y

—

Profile

Pros

Company has delivered good profit growth of 65.2% CAGR over last 5 years

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has high debtors of 203 days.
Working capital days have increased from 130 days to 199 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.50 pts; domestic institutions added 0.44 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

67%

Promoter

Promoters

67.0%+0.04

Public

21.8%+0.01

FII / FPI

0.0%-0.50

DII

11.2%+0.44

Total shareholders

550-53 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter67.05%

DII11.17%

Public21.78%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]